Basic Information
| RNALocate ID: | RLID-D:11000741 |
| RNA Symbol: | hsa-miR-940 |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-940 |
| RNA ID: | miRBase:MIMAT0004983 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Fibroblasts|Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002718 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002719 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11004194 | Exosome | Plasma | 23663360 |
| RLID:11004195 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11004196 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11001620 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-940 | Multiple sclerosis chronic progressive | MNDR-E-MI-72099 |
| MNDR | hsa-miR-940 | Oral squamous cell carcinoma | MNDR-E-MI-72100 |
| MNDR | hsa-miR-940 | B cell lymphoma of malt type | MNDR-E-MI-72101 |
| MNDR | hsa-miR-940 | High-grade serous ovarian carcinoma | MNDR-E-MI-72102 |
| MNDR | hsa-miR-940 | Uterine corpus endometrial carcinoma | MNDR-E-MI-72103 |
| MNDR | hsa-miR-940 | Lymphoma | MNDR-E-MI-72104 |
| MNDR | hsa-miR-940 | Estrogen-receptor positive breast cancer | MNDR-E-MI-72105 |
| MNDR | hsa-miR-940 | Progesterone-receptor positive breast cancer | MNDR-E-MI-72106 |
| MNDR | hsa-miR-940 | Prostate cancer | MNDR-E-MI-72107 |
| MNDR | hsa-mir-940 | Prostate cancer | MNDR-E-MI-72108 |
| MNDR | hsa-miR-940 | Gastric cancer | MNDR-E-MI-72109 |
| MNDR | hsa-mir-940 | Gastric cancer | MNDR-E-MI-72110 |
| MNDR | hsa-miR-940 | Alzheimer disease | MNDR-E-MI-72111 |
| MNDR | hsa-miR-940 | Intracranial aneurysm | MNDR-E-MI-72112 |
| MNDR | hsa-mir-940 | Bladder cancer | MNDR-E-MI-72113 |
| MNDR | hsa-miR-940 | Seizures | MNDR-E-MI-72114 |
| MNDR | hsa-miR-940 | Leukemia | MNDR-E-MI-72115 |
| MNDR | hsa-miR-940 | Lung cancer | MNDR-E-MI-72116 |
| MNDR | hsa-miR-940 | Parkinson disease | MNDR-E-MI-72117 |
| MNDR | hsa-miR-940 | Breast cancer | MNDR-E-MI-72118 |
| MNDR | hsa-mir-940 | Neoplasms | MNDR-E-MI-72119 |
| MNDR | hsa-miR-940 | Pancreatic cancer | MNDR-E-MI-72120 |
| MNDR | hsa-miR-940 | Nephroblastoma | MNDR-E-MI-72121 |
| MNDR | hsa-miR-940 | Colon cancer | MNDR-E-MI-72122 |
| MNDR | hsa-miR-940 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-72123 |
| MNDR | hsa-miR-940 | Carcinoma ductal breast | MNDR-E-MI-72124 |
| MNDR | hsa-miR-940 | Invasive ductal carcinoma | MNDR-E-MI-72125 |
| MNDR | hsa-miR-940 | Glioblastoma | MNDR-E-MI-72126 |
| MNDR | hsa-mir-940 | Glioblastoma | MNDR-E-MI-72127 |
| MNDR | hsa-miR-940 | Malignant glioma | MNDR-E-MI-72128 |
| MNDR | hsa-miR-940 | Amyotrophic lateral sclerosis | MNDR-E-MI-72129 |
| MNDR | hsa-miR-940 | Osteosarcoma | MNDR-E-MI-72130 |
| MNDR | hsa-miR-940 | Breast carcinoma | MNDR-E-MI-72131 |
| MNDR | hsa-miR-940 | Pancreatic ductal adenocarcinoma | MNDR-E-MI-72132 |
| MNDR | hsa-miR-940 | Middle cerebral artery infarction | MNDR-E-MI-72133 |
| MNDR | hsa-miR-940 | Gastric adenocarcinoma | MNDR-E-MI-72134 |
| MNDR | hsa-miR-940 | Lung squamous cell carcinoma | MNDR-E-MI-72135 |
| MNDR | hsa-miR-940 | Lung adenocarcinoma | MNDR-E-MI-72136 |
| MNDR | hsa-miR-940 | Thyroid carcinoma | MNDR-E-MI-72137 |
| MNDR | hsa-miR-940 | Ovarian carcinoma | MNDR-E-MI-72138 |
| MNDR | hsa-miR-940 | Bladder urothelial carcinoma | MNDR-E-MI-72139 |
| MNDR | hsa-miR-940 | Myasthenia gravis autoimmune experimental | MNDR-E-MI-72140 |
| MNDR | hsa-miR-940 | Kidney renal clear cell carcinoma | MNDR-E-MI-72141 |
| MNDR | hsa-miR-940 | Renal clear cell carcinoma | MNDR-E-MI-72142 |
| MNDR | hsa-mir-940 | Pancreatic carcinoma | MNDR-E-MI-72143 |
| MNDR | hsa-miR-940 | Cholangiocarcinoma | MNDR-E-MI-72144 |
| MNDR | hsa-miR-940 | Lung small cell carcinoma | MNDR-E-MI-72145 |
| MNDR | hsa-miR-940 | Head and neck squamous cell carcinoma | MNDR-E-MI-72146 |
| MNDR | hsa-miR-940 | Testicular germ cell cancer | MNDR-E-MI-72147 |
| MNDR | hsa-miR-940 | Adenoma | MNDR-E-MI-72148 |
| MNDR | hsa-miR-940 | Breast invasive carcinoma | MNDR-E-MI-72149 |
| MNDR | hsa-miR-940 | Hepatocellular carcinoma | MNDR-E-MI-72150 |
| MNDR | hsa-mir-940 | Hepatocellular carcinoma | MNDR-E-MI-72151 |
| MNDR | hsa-miR-940 | B-cell lymphoma | MNDR-E-MI-72152 |
| MNDR | hsa-miR-940 | Malignant pleural mesothelioma | MNDR-E-MI-72153 |
| MNDR | hsa-miR-940 | Hodgkin lymphoma | MNDR-E-MI-72154 |
| MNDR | hsa-miR-940 | Colorectal cancer | MNDR-E-MI-72155 |
| MNDR | hsa-miR-940 | Nasopharynx carcinoma | MNDR-E-MI-72156 |
| MNDR | hsa-miR-940 | Nasopharyngeal cancer | MNDR-E-MI-72157 |
| MNDR | hsa-miR-940 | Subarachnoid hemorrhage traumatic | MNDR-E-MI-72158 |
| MNDR | hsa-miR-940 | Breast cancer her3+ negative | MNDR-E-MI-72159 |
| MNDR | hsa-miR-940 | Tubulovillous adenoma | MNDR-E-MI-72160 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CD274 | Homo sapiens | RR00300246 |
TOP